IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,000 | -7.1% | 10,200 | +32.5% | 0.01% | 0.0% |
| Q1 2018 | $14,000 | -6.7% | 7,700 | +6.9% | 0.01% | -14.3% |
| Q4 2017 | $15,000 | +200.0% | 7,200 | +200.0% | 0.01% | +250.0% |
| Q3 2017 | $5,000 | -28.6% | 2,400 | -41.5% | 0.00% | -50.0% |
| Q2 2017 | $7,000 | -22.2% | 4,100 | +13.9% | 0.00% | -20.0% |
| Q1 2017 | $9,000 | +80.0% | 3,600 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $5,000 | -58.3% | 3,600 | -25.0% | 0.00% | -57.1% |
| Q3 2016 | $12,000 | +71.4% | 4,800 | -2.0% | 0.01% | +75.0% |
| Q2 2016 | $7,000 | -30.0% | 4,900 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $10,000 | -33.3% | 4,900 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $15,000 | -6.2% | 4,900 | 0.0% | 0.01% | -20.0% |
| Q3 2015 | $16,000 | -5.9% | 4,900 | +6.5% | 0.01% | 0.0% |
| Q2 2015 | $17,000 | +13.3% | 4,600 | +12.2% | 0.01% | +11.1% |
| Q1 2015 | $15,000 | – | 4,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,525,000 | $7,874,000 | 1.40% |
| DAFNA Capital Management LLC | 200,000 | $348,000 | 0.38% |
| HealthCor Management, L.P. | 3,270,000 | $5,690,000 | 0.30% |
| Baker Brothers Advisors | 5,865,000 | $10,205,000 | 0.14% |
| Spark Investment Management LLC | 152,500 | $262,000 | 0.06% |
| NATIXIS | 3,148,916 | $5,479,000 | 0.06% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $647,000 | 0.05% |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $141,000 | 0.02% |
| TFS CAPITAL LLC | 118,232 | $206,000 | 0.01% |
| First Eagle Investment Management, LLC | 1,434,296 | $2,496,000 | 0.01% |